
Cigna's ticker symbol is CI, which is listed on the New York Stock Exchange (NYSE). This is the stock market where investors can buy and sell shares of Cigna.
Cigna is a global health insurance company that operates in over 30 countries worldwide. Their global presence is a testament to their financial stability and growth.
Cigna's financial performance is reflected in their revenue, which has consistently increased over the years. In 2020, their revenue reached $148.4 billion, a significant growth from previous years.
The financial insights provided by Cigna's stock performance and revenue growth offer valuable information for investors and analysts.
Financial Analysis
The Cigna Group's revenue in 2024 was a whopping $247.12 billion, a 26.56% increase from the previous year's $195.27 billion.
This significant growth in revenue is a testament to the company's strong financial performance. Earnings, however, took a hit, decreasing by 33.50% to $3.43 billion.
Investment Opportunity
Cigna's stock has been a steady performer, with a dividend yield of 1.5% in 2022. This is a relatively low-risk investment option for those seeking regular income.
The company's financials are solid, with a debt-to-equity ratio of 0.4, indicating manageable debt levels. This stability can provide a sense of security for investors.
Cigna's revenue has been steadily increasing, with a 5-year average annual growth rate of 8.5%. This growth can lead to higher stock prices and more opportunities for investors.
Investors seeking long-term growth may want to consider Cigna's stock, as it has a 5-year average annual return of 12.5%. This growth potential can be attractive to those willing to hold onto their shares for an extended period.
Cigna's stock has a beta of 0.8, indicating lower volatility compared to the broader market. This can be beneficial for investors who want to minimize their risk exposure.
Frequently Asked Questions
What is the target price for Cigna stock in 2024?
The target price for Cigna stock is forecasted to be between $348.00 and $438.00, representing a potential upside of 41.60% from the current price. This forecast is based on analyst predictions and may not reflect actual market performance.
Featured Images: pexels.com